VAERS ID: 1294834

AGE: 69| SEX: M|STATE: LA (United States)

Description

Progressive Limbic Encephalitis; inattention; short term memory loss; apraxia; slow cognitive speeds; Recurrence of Limbic Encephalitis/Progressive Limbic Encephalitis; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of LIMBIC ENCEPHALITIS (Recurrence of Limbic Encephalitis/Progressive Limbic Encephalitis), CONDITION AGGRAVATED (Progressive Limbic Encephalitis), ATTENTION DEFICIT HYPERACTIVITY DISORDER (inattention), AMNESIA (short term memory loss), APRAXIA (apraxia) and COGNITIVE DISORDER (slow cognitive speeds) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012MZ0A and 012A21A) for COVID-19 vaccination. The patient's past medical history included Limbic encephalitis in September 2020. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced LIMBIC ENCEPHALITIS (Recurrence of Limbic Encephalitis/Progressive Limbic Encephalitis) (seriousness criteria hospitalization and medically significant), ATTENTION DEFICIT HYPERACTIVITY DISORDER (inattention) (seriousness criteria hospitalization and medically significant), AMNESIA (short term memory loss) (seriousness criteria hospitalization and medically significant), APRAXIA (apraxia) (seriousness criteria hospitalization and medically significant) and COGNITIVE DISORDER (slow cognitive speeds) (seriousness criteria hospitalization and medically significant). On 22-Mar-2021, the patient experienced CONDITION AGGRAVATED (Progressive Limbic Encephalitis) (seriousness criterion hospitalization). At the time of the report, LIMBIC ENCEPHALITIS (Recurrence of Limbic Encephalitis/Progressive Limbic Encephalitis), CONDITION AGGRAVATED (Progressive Limbic Encephalitis), ATTENTION DEFICIT HYPERACTIVITY DISORDER (inattention), AMNESIA (short term memory loss), APRAXIA (apraxia) and COGNITIVE DISORDER (slow cognitive speeds) outcome was unknown. Not Provided mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient was treated with Plasma Pherisis x7 exchanges plus IV methylprednisolone followed by Prednisone taper.; Sender's Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient's comorbidities.

Open in Wayback Machine
(If this is a foreign report without a description you will be able to read the description in the Wayback Machine on Medalerts if the report became public for the first time before November 18, 2022.)

Symptoms

Amnesia, Condition aggravated, Cognitive disorder, Apraxia, Attention deficit hyperactivity disorder, Limbic encephalitis

Vaccines

VAX DATE: 02-09-2021| ONSET DATE: 02-09-2021| DAYS TO ONSET: 0
NameDose #TypeManufacturerLotRouteSite
COVID19 (COVID19 (MODERNA)) 2 COVID19 MODERNA 012MZ0A OT Unknown

RECVDATE:05-07-2021
RPT_DATE:
CAGE_YR:68
CAGE_MO:
DIED:U
DATEDIED:
L_THREAT:U
ER_VISIT:
HOSPITAL:Y
HOSPDAYS:
X_STAY:U
DISABLE:U
RECOVD:U
LAB_DATA:
V_ADMINBY:
OTHER_MEDS:
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Limbic encephalitis
PRIOR_VAX:
SPLTTYPE:USMODERNATX, INC.MOD20210
FORM_VERS:
TODAYS_DATE:05-07-2021
BIRTH_DEFECT:U
OFC_VISIT:U
ER_ED_VISIT:U
ALLERGIES:
V_FUNDBY:

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.